1. Herbst AL, Ulfelder H, Poskanzer DC. Adenocarcinoma of the vagina. Association of maternal stilboestrol therapy with tumor appearance in young women. N Engl J Med1971;284:878–81.
2. Newbold RR, McLachlan JA. Transplacental hormonal carcinogenesis: diethylstilbestrol as an example. In: Huff J, Boyd J, Barrett JC. (eds). Cellular and Molecular Mechanisms of Hormonal Carcinogenesis: Environmental Influences. New York: Wiley Liss & Sons, 1996, pp. 131–47.
3. Schrager S, Potter BE. Diethylstilbestrol exposure. Am Fam Phys2004;69:2395–400.
4. Baird DD, Newbold RR. Prenatal diethylstilbestrol (DES) exposure is associated with uterine leiomyoma development. Reprod Toxicol2005:20:81–84.
5. McLachlan JA, Newbold RR, Bullock BC. Long-term effects on the female mouse genital tract associated with prenatal exposure to diethylstilbestrol. Cancer Res1980:40:3988–99.